MACC1 as a prognostic biomarker for early-stage and AFP-normal hepatocellular carcinoma.
<h4>Background</h4>The metastasis-associated in colon cancer 1 gene (MACC1) has been found to be associated with cancer development and progression. The aim of this study was to investigate the prognostic value of MACC1 in early-stage and AFP-normal hepatocellular carcinoma (HCC).<h4&...
Main Authors: | Chan Xie, Jueheng Wu, Jingping Yun, Jiaming Lai, Yunfei Yuan, Zhiliang Gao, Mengfeng Li, Jun Li, Libing Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/23717574/?tool=EBI |
Similar Items
-
Identification of <it>MACC1 </it>as a novel prognostic marker in hepatocellular carcinoma
by: Lu Canliang, et al.
Published: (2011-09-01) -
Multiplexed Proteomic Approach for Identification of Serum Biomarkers in Hepatocellular Carcinoma Patients with Normal AFP
by: Young-Sun Lee, et al.
Published: (2020-01-01) -
TEMs but not DKK1 could serve as complementary biomarkers for AFP in diagnosing AFP-negative hepatocellular carcinoma.
by: Liping Mao, et al.
Published: (2017-01-01) -
New Blood Biomarkers for the Diagnosis of AFP-Negative Hepatocellular Carcinoma
by: Ting Wang, et al.
Published: (2020-08-01) -
Identification of Plasma hsa_circ_0005397 and Combined With Serum AFP, AFP-L3 as Potential Biomarkers for Hepatocellular Carcinoma
by: Ruoyu Liu, et al.
Published: (2021-02-01)